The New York Times
– Oct 9, 2019, 2:57 PM
A new drug, created to treat just one patient, has pushed the bounds of personalized medicine and has raised unexplored regulatory and ethical questions, scientists reported on Wednesday. The drug, described in the New England Journal of Medicine…
New England Journal of Medicine
– Oct 9, 2019, 2:00 PM
In 1850, the Scottish physician William MacIntyre described one of the earliest documented cases of multiple myeloma (MM) in the report “ Case of mollities and fragilitas ossium, accompanied with urine strongly charged with animal…
Hemoconcentration during the treatment of acute decompensated heart failure is a surrogate for plasma volume reduction and is associated with improved survival, but most definitions only allow for hemoconcentration to be determined retrospectively.